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Abstract 
Periprosthetic joint infection (PJI) is a devastating and costly post-surgical complication 
that is not well understood due to the scarcity of physiologically representative 
experimental models. This thesis outlines the development of two 3D bioartificial human 
tissue models designed to study the cellular and biochemical interactions between 
primary fibroblasts from the shoulder capsule (SC) and infectious microorganisms. Using 
the Fibroblast-Bacteria Co-culture in 3D Collagen model, we demonstrated a global gene 
repression of metabolic and homeostatic processes in SC fibroblasts following 48 hours 
of co-culture with Cutibacterium acnes – the most common microbial cause of PJI in the 
shoulder. These cellular changes coincided with an increase in pro-inflammatory 
signaling. The Shoulder-Joint Implant Mimetic (S-JIM) model generated a range of 
oxygen levels (< 0.3% to 21% O2) that accurately represents the different 
microenvironments present across connective tissue layers in a shoulder joint. Electron 
microscopy images confirmed that the hypoxic conditions generated in the core of the S-
JIM supported the anaerobic proliferation of C. acnes, but this microbial expansion 
resulted in the death of adjacent SC fibroblasts after 96 hours of co-culture. Using the S-
JIM, we demonstrated the bactericidal effectiveness of direct vancomycin prophylaxis 
against C. acnes and confirmed the possibility of differentiating between healthy host 
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Summary for Lay Audience Abstract 
Bacterial infection may sometimes develop on the surface of an implant after joint 
replacement surgery. These complications can have devastating consequences on a 
patient’s physical and mental wellbeing, resulting in a heavy healthcare burden. The 
shoulder joint is particularly susceptible to infection by Cutibacterium acnes – a species 
of skin bacteria that may begin to proliferate in the low-oxygen environment close to the 
implant. The details on how a C. acnes infection damages the shoulder joint is not well 
understood at present due to limitations in our current models of joint infection. 
In this thesis, we outline the development of two novel laboratory models of joint 
infection that were created using human shoulder cells. Our first model, the Fibroblast-
Bacteria Co-culture in 3D Collagen, was designed to assess for changes in the expression 
of genes in shoulder cells following an artificially induced C. acnes infection. We 
observed an overall decrease in the expression of genes that regulate cell stability and 
growth, but an increase in the expression of genes that signal for an inflammatory 
response. These changes in the shoulder cells are consistent with the physiological 
responses that would be present following joint infection in a patient. 
Our second model, the Shoulder-Joint Implant Mimetic (S-JIM) was designed to replicate 
the low-oxygen conditions that would be generated near the implant surface by the many 
layers of dense shoulder tissue surrounding the implant. Microscope images confirmed 
that the low-oxygen conditions generated in the core of the S-JIM supported the 
proliferation of C. acnes, and that this continued microbial growth killed adjacent 
shoulder cells after 96 hours. Using the S-JIM, we also demonstrated that the preemptive 
application of vancomycin powder (a first-choice antibiotic for clearing orthopedic 
infections) was successful at completely eradicating C. acnes cells from the model and 
prevented the development of infection. Finally, we provided proof-of-concept for the 
use of mass spectrometry – a method of detecting specific molecular markers – to 
differentiate between healthy shoulder tissues and tissues infected with C. acnes. 
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Chapter 1 
1 LITERATURE REVIEW 
1.1 Periprosthetic Joint Infection (PJI) 
1.1.1 Overview 
Infection occurs when microorganisms invade a host organism’s tissues and disturb the 
native cellular environment by secreting disease-causing toxins and/or by usurping local 
cellular resources for their own rapid proliferation. These microbial activities can 
destabilize the host organism’s native microbiota and disrupt essential biological 
processes, such as cell signaling and tissue regeneration.  
In humans, infection develops infrequently in internal organs and tissues as they are 
shielded from exogenous pathogens by thick layers of skin, fat, and muscle. However, in 
the event of an injury, internal organs and tissues may be exposed to airborne 
contaminants and microorganisms from other parts of the body, allowing opportunistic 
pathogens to colonize these previously inaccessible regions. 
Surgery is a special type of artificial injury that may inadvertently enable microbial 
invasion of human tissues. For example, in joint replacement surgery, the process of 
reconstructing a functional joint can expose adjacent connective tissues to bacteria from 
the surrounding dermis. Although precautions are generally taken to avoid contact 
between the joint cavity and dermal layers, technical errors during the operation can 
result in cross-contamination of tissues. In most US hospitals, joint infection occurs in 
about 0.5% to 2% of knee replacements, 0.5% to 1.0% of hip replacements, and less than 
1% of shoulder replacements.1–3 
The human joint cavity provides an advantageous microenvironment for the proliferation 
of anaerobic bacteria. In the rotator cuff (i.e., the muscles and tendons that support the 
shoulder joint), primary tenocytes grow optimally under low-oxygen (2% O2), but they 
stop growing and differentiate toward a tissue repair-associated myofibroblast phenotype 
when cultured under atmospheric oxygen levels (21% O2) Figure 1.1. The adaptation of 
2 
these cells to grow under low-oxygen conditions in vitro is reflective of low-oxygen 
conditions in the joint. Compared to the oxygen availability in most other human tissues4, 
the shoulder joint cavity is relatively hypoxic (Table 1).  
The microenvironment within a post-surgical joint cavity is hypothesized to be even more 
hypoxic than in normal joints, as prosthetic joints do not have the vasculature of a normal 
joint. Instead, the addition of an artificial implant induces the foreign body reaction – a 
non-specific immune response whereby the implant becomes encapsulated in a dense 
layer of fibrotic connective tissue.5 This scar-like tissue has poor vascularity, which when 
combined with the avascular nature of the metal implant, limits the rate of oxygen 
diffusion into the joint cavity. This in turn generates an abnormally hypoxic 
microenvironment that can provide anaerobic pathogens with a fitness advantage and 





Figure 1.1. Proliferation of Primary Tenocytes in 3D Collagen. 
Growth of primary tenocytes derived from the supraspinatus and subscapularis tendons 
from normal rotator cuff (NRC, patient age 18 - 35 years), adult rotator cuff (ARC, 
patient age 36 - 65 years) and torn rotator cuff (RCD, patient age 60 -75 years).  Under 
21% O2, tenocytes displayed rapid growth rates initially that consistently plateaued after 
3 days and cells developed a myofibroblast-like morphology with multiple cellular 
processes. Under 2% O2, the cells grew more slowly and constantly while maintaining a 
typical rounded tenocyte morphology. Unpublished data by Athir Jisrawi (O’Gorman 
laboratory) generated prior to the commencement of this thesis. 
4 
Table 1.1 Normal oxygen percentage in the microenvironment of various tissues.4 
Human tissue % O2 
Bone marrow 6.4 ± 0.6 
Brain 4.4 ± 0.3 
Lungs 5.6 
Skin (sub-papillary plexus) 4.6 ± 1.1 
Skin (dermal papillae) 3.2 ± 0.8 
Skin (superficial region) 1.1 ± 0.4 
Intestinal tissue 7.6 ± 0.3 
Liver 5.4 ± 0.7 
Kidney 9.5 ± 2.6 













1.1.2 Healthcare Burden 
PJI results from a failure to maintain aseptic conditions during arthroplasty (i.e. the 
surgical reconstruction or replacement of a joint) and remains one of the leading causes 
of revision surgery worldwide.6 Infection can occur following the replacement of any 
joint, including the hip, knee, shoulder, elbow, wrist, ankle, temporomandibular, 
metacarpophalangeal, and interphalangeal joints. However, the vast majority of PJI cases 
involve the hip, knee, and shoulder joints as these surgeries are more routinely 
performed.7  
PJI places a heavy burden on healthcare spending. While only 1 to 3% of arthroplasty 
patients develop PJIs, the costs associated with managing infection are staggering.8 
Multiple revision surgeries may be required to control a persistent infection. For example, 
revision of a knee arthroplasty may cost 3 to 4 times as much as the initial operation due 
to a higher number of operations and examinations, and longer operative times.9 
Moreover, the failure rate for revision surgery can be as high as 33%.10 In the US, the 
estimated annual cost of treating PJI in 2020 is $1.62 billion.11 
1.1.3 PJI Management 
Periprosthetic joint infection generally develops as a result of surgical contamination, but 
an estimated 20% to 35% of cases may also arise from hematogenous spread.12 The latter 
situation arises when a patient with a pre-existing prosthetic joint encounters an injury 
that allows bacteria from the wound to enter the circulation and eventually permeate the 
periprosthetic tissues. In both cases, routine treatment of PJI involves the surgical 
removement of the implant, followed by debridement and irrigation of periprosthetic 
tissues.13 Once new implant parts are reintroduced, patients are typically placed on long-
term antibiotic therapy (~12 weeks), applied intravenously for the first two weeks and 
orally afterwards.14 The type and dosage of antibiotic used depends on the microbial 
source of infection, which is detected by collecting and culturing of intraoperative biopsy 
samples.14 In the case that infection cannot be controlled, the joint may need be 
amputated or permanently immobilized.15 
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PJI presents a clinical challenge as infection may persist after several revision surgeries, 
and patients who undergo repeated operations can develop permanent complications. 
Prolonged suppressive antibiotic therapy (either oral or intravenous) provides an 
alternative to further surgery. However, intraoperative antibiotics may disrupt the joint 
microbiota and oral antibiotics may disrupt the gut microbiota. Furthermore, both routes 
of antibiotic delivery risk promoting microbial resistance, and some patients may develop 
adverse drug reactions.16  
The antibiotic vancomycin is a popular prophylaxis to orthopedic infections. In spinal 
fusion and shoulder replacement surgery, vancomycin powder is typically applied 
directly into the surgical site.17,18 However, the effectiveness of vancomycin in 
preventing PJIs is currently unclear, as large numbers of patient samples are required to 
conduct high-quality studies such as randomized controlled trials due to the low 
incidence of PJI in most hospitals. However, there are two potential problems with its 
prophylactic application. First, similar to prolonged suppressive antibiotic therapy, the 
use of vancomycin may promote microbial resistance. Second, a high serum 
concentration of vancomycin can increase the risk of renal function deterioration.19  
1.1.4 Symptoms and Risk Factors 
Common reported symptoms of PJI include non-specific pain, joint effusion or drainage, 
erythema, and fever.20 PJI can also lead to serious clinical consequences such as tissue 
necrosis and implant loosening.21 General risk factors include tobacco abuse, obesity, 
rheumatoid arthritis, tumor growth, immunosuppression, and diabetes mellitus. A history 
of prior surgery at the site of operation and the duration of surgery itself can also increase 
the risk of PJI.22 PJI can be classified as either acute (<4 weeks after surgery and <3 
weeks of symptoms) or chronic (≥ 4 weeks after surgery and ≥ 3 weeks of symptoms), 
depending on the onset and duration of symptoms.7 PJIs caused by surgical 
contamination typically present symptoms within the first month, whereas PJIs arising 
from hemorrhagic spread  may occur at any point after the initial operation.23  
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1.1.5 PJI in the Shoulder 
The shoulder joint is one of the most common sites of arthroplasty. In the US, 53,000 
total shoulder arthroplasties are performed annually.24 Cutibacterium acnes is responsible 
for ~60% of all post-surgical cases of PJI in the shoulder, making it the most common 
microbial cause of infection in this region.25 This contrasts with PJI in the knee and hip, 
whereby Staphylococcus aureus is the most common microbial pathogen.26  
 
1.2 Cutibacterium acnes 
1.2.1 Microbiology 
Cutibacterium acnes is a gram-positive, nonsporulating bacillus that resides naturally 
within the pilosebaceous follicles of human skin.27,28 As one of the most common 
commensal microorganisms of human skin, C. acnes represents up to 90% of the 
microbiota in some regions of the reticular dermis, such as the face, back, upper chest, 
and shoulder.29–32 Cutibacterium acnes thrives in this lipid-rich microenvironment by 
using its unique set of enzymes to metabolize sebum constituents into simple fats and 
carbohydrates. For example, C. acnes expresses two secretory lipases that degrade 
triglycerides, a sialidase that cleaves sialoglycoconjugates into sialic acid, and two 
putative endoglycoceramidases that are thought to break down oligosaccharides and 
glycosphingolipids.33  
The metabolic activity of C. acnes confers a protective function for the skin. By 
metabolizing sebum, C. acnes generates large quantities of the byproduct propionic acid, 
as well as other short chain fatty acids that help to maintain a low skin pH. These acidic 
conditions exclude microbial pathogens such as Staphylococcus and Streptococcus 
species from colonizing the skin.33,34  
The ability of C. acnes to produce propionic acid has resulted in its previous 
misclassification under the genus Propionibacteria. In 2016, a reclassification effort was 
undertaken to differentiate the environmental species found in dairy products and cattle 
rumen from the cutaneous species that have evolved to live in human skin. Whole-
8 
genome analyses of strains belonging to the Propionibacteriaceae family identified 
specific lipase-encoding genes for degrading sebum lipids in the cutaneous bacteria, 
while several Propionibacteriaceae genes appeared to be lost. Substantial discrepancies 
were also found in the 16S rRNA gene sequence between the two bacterial groups, 
implying early divergent evolution. Because of these phylogenetic differences, the 
cutaneous bacteria previously recognized as Propionibacterium species were reclassified 
under the new genus Cutibacterium.35  
Cutibacterium acnes is a robust microorganism. While officially classified as an 
aerotolerant anaerobe, cutaneous C. acnes strains have been isolated by primary aerobic 
culture in as high as 28% of test subjects.36 This implies that a substantial number of C. 
acnes strains possess both aerobic and anaerobic modes of growth. Genomic and 
transcriptomic analyses also support this notion. For example, Brzuszkiewicz et al. 
recorded the presence and gene expression of two respiratory endoxidases in C. acnes.37 
The trigger(s) that activate or deactivate each mode of growth are not well understood, 
but the ability of C. acnes to react to changing oxygen levels affords the bacterium 
increased survivability compared to strict anaerobes.  
Cutibacterium acnes is a relatively slow-growing microorganism with an average 
doubling rate of 5 to 12 hours under anaerobic cell culture conditions; this doubling rate 
can vary dramatically depending on the strain phylotype and culture media selection.38–40 
In its planktonic form, C. acnes divides by binary fusion and has a rod-like morphology 
that lacks pili-like appendices on its cell wall.41  
1.2.2 Opportunistic Pathogen 
C. acnes contributes to a variety of human-related diseases, including acne vulgaris, 
sarcoidosis, aortic aneurysms, and several types of implant-associated infections.42 This 
has led researchers to view C. acnes not just as a skin commensal, but also as a potential 
opportunistic pathogen, particularly in the context of orthopedic infections. Recent 
microbiota analyses of the shoulder joint support this notion. When the bacterial 
microbiota of patient rotator cuff and skin samples were compared, ribosomal RNA 
(rRNA) gene sequences specific to Cutibacterium species were absent in the joint but 
9 
present in the skin, implying that C. acnes-associated PJI is a result of dermal 
contamination during surgery.43 Figure 1.2 illustrates the relative proximity of the 











Figure 1.2. The shoulder joint capsule during arthroplasty. 
Cutibacterium acnes colonizes the sebum-rich regions of subcutaneous tissues. Routine 
preoperative sterilization procedures can decontaminate skin surfaces on the shoulder, but 
they do not impact surgically exposed subcutaneous tissues.44 In the process of replacing 
the humeral head, any tools that inadvertently graze the subcutaneous tissues risk 
introducing C. acnes into the joint cavity. Once the synovial membrane is re-ligated, the 
joint cavity eventually becomes hypoxic, which favors C. acnes proliferation. Image was 






1.2.3 Biofilm Formation 
Microbial biofilms are complex communities of microorganisms that are attached to a 
surface and encapsulated within a matrix of extracellular polymeric substances.45 Biofilm 
formation occurs in four stages: cell adherence, cellular aggregation, biofilm maturation, 
and cellular detachment. Initially, adhesion proteins or appendices on microbial cell walls 
form weak, transient interactions with the surface of an implant. Once adhered, cells 
begin to divide rapidly, forming aggregates of microcolonies. Once a critical microbial 
density is reached, cells slow their proliferation and begin to secrete autoinducers that 
transmit quorum signals to alter global gene expression. This causes the bacteria to 
secrete a meshwork of extracellular polymeric substances (EPS) – including 
polysaccharides, lipids, proteins, and extracellular DNA – that together constitute a 
biofilm matrix. As the meshwork of EPS builds up, cells are encased within the matrix 
and become immobilized. Over time, sessile cells on the biofilm outskirts can 
occasionally detach, regain motility, and return to a planktonic mode of growth. These 
freed bacteria can then go on to form new biofilm microcolonies on other sites of the 
surface.45–50  
During arthroplasty, C. acnes may be unwittingly transferred from the dermis to the 
surgical site, where it adheres to the implant surface and begins to form a biofilm once a 
critical microbial density is achieved. Once the biofilm has matured, it can provide C. 
acnes with a hypoxic environment that is favorable for survival, act as a barrier to 
antimicrobials and immune cell infiltration, and confer protection from shear stresses 
caused by joint movement.45,51 Furthermore, the metabolic activity of C. acnes is greatly 
reduced in a mature biofilm, which can mask the microorganism from detection.52 C. 
acnes biofilm formation has been observed on a wide range of materials of variable shape 
and hardness. The chemical composition of the C. acnes biofilm, the genes encoding it, 
and the factors that regulate it are not well understood.45 
C. acnes biofilms are clinically important as they appear to hinder the host wound repair 
process in a manner that is unrelated to the inherent pathogenicity of planktonic C. acnes 
cells. For example, the mannose content in C. acnes biofilms are much higher than the 
sum total produced by an equivalent cell count of planktonically-grown C. acnes.45 
12 
Mannose is known inhibit the synthesis of hyaluronan – a glycosaminoglycan and major 
extracellular matrix scaffold component that is involved in the formation of granulation 
tissue (i.e. new connective tissue and capillaries that form a scaffold for wound 
healing).53  
The ability of C. acnes to form biofilms within artificial joints is arguably the main 
reason PJIs are so difficult to manage. While several widely used antimicrobials are 
effective against planktonic C. acnes at sub-micromolar concentrations (daptomycin, 
vancomycin, levofloxacin, penicillin, clindamycin, and ceftriaxone), they are clinically 
ineffective at eradicating C. acnes embedded in biofilms.51 Rifampicin appears to be one 
of the most effective antibiotics at killing sessile bacteria that live within biofilms, but 
reports have shown it is unable to consistently eradicate C. acnes in its entirety. 
Moreover, a recent study found several clinical C. acnes strains have developed 
resistance to rifampicin.54  
C. acnes biofilms can harbor other pathogenic microbes involved in PJI and enhance their 
virulence. For example, C. acnes is commonly co-isolated with Staphylococcus aureus in 
polymicrobial PJIs, and the secretion of a C. acnes CAMP factor has been shown to 
cause a two-fold increase in the hemolytic and cytolytic activity in S. aureus.55 
Furthermore, C. acnes appears to facilitate long-term survival of S. aureus by expressing 
a gene that promotes porphyrin metabolism into coproporphyrin III, which contributes to 
the aggregation S. aureus cells and the formation of a polymicrobial biofilm.56 Tyner and 
Patel (2016) showed that S. aureus survival rates were indeed higher in polymicrobial 
biofilms containing C. acnes relative to biofilms containing only S. aureus.57  
 
1.2.4 Diagnostic Challenges 
C. acnes PJIs are difficult to diagnose, as symptoms of infection are typically not present 
until weeks or months after the initial operation.25 It is possible that C. acnes infections 
are initially indolent because microbial expansion requires low oxygen conditions 
generated by the metabolism of surrounding host tissues.  
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Common inflammatory biomarkers such as C-reactive protein, erythrocyte sedimentation 
rate, and white blood cell count cannot reliably detect a C. acnes infection.58,59 
Consequently, routine detection of C. acnes infections involves anaerobic culturing of 
intraoperative biopsy samples – a process that requires a minimum of 10 days.12,60–62 This 
slow detection approach is not only extremely slow, but it is also subject to the high 
possibility of contamination during sample collection and culture. Consequently, an 
estimated 20% of PJI cases involving C. acnes are false positive diagnoses.63 
Recently, a genetic-based diagnostic assay has been developed for confirming a C. acnes-
associated infection with greater speed (< 24 hours) and accuracy compared to routine 
microbial cultures.64 This assay involves a two-step approach. First, a region of the C. 
acnes 16S rRNA gene with high species-specificity is amplified by polymerase chain 
reaction. Next, the presence of a uniquely C. acnes nucleotide polymorphism site is 
confirmed in this amplified region by enzymatic digest with HindIII. While this detection 
assay is highly sensitive and specific for C. acnes, it has yet to realize widespread clinical 
adoption due to prohibitive machinery costs and the technical expertise required to obtain 
a diagnosis. The ideal detection approach for C. acnes-associated PJI would be a point-
of-care assay that can provide an accurate diagnosis while the patient is on the operating 
table, allowing surgeons to employ prophylactic measures during surgery. 
 
1.3 Current models of PJI 
1.3.1 Overview 
Models are important in that they allow researchers to directly investigate disease 
characteristics and potential treatments. Models of PJI provide a preclinical landscape for 
the development of novel anti-infection therapies, screening of potential biomarkers, and 
validation of current clinical approaches to managing infection. In the 2019 Proceedings 
of the International Consensus on Orthopedic Infections, the scarcity of joint infection 
models was identified as an unmet need in orthopedic research.60 The development of 
novel models with high preclinical validity and are easy to adopt is imperative to further 
our understanding of PJI. Existing models of PJI can be classified as either in vivo 
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(animal models) or ex vivo (cell culture-based models), both of which include distinct 
advantages and limitations. 
1.3.2 Animal Models 
Large animal species have been previously used to model orthopedic infection in 
humans. The impact of microbial biofilms on joint infection has been studied in goats and 
sheep65,66, and the risk factors of infection have been extrapolated retrospectively from 
horses.67 However, the use of large animals is not routinely adopted in the study of 
orthopedic infection due to prohibitive costs and ethical concerns.68  
The use of smaller animals as models, such as mice and rabbits, is more routine. While 
the types of implant mimetics and the method of introducing these implants may differ 
amongst technicians, several studies have successfully replicated microbial biofilm 
formation in these animals.52,69,70 However, small animal models of PJI generally provide 
an inaccurate reflection of PJI in human patients due to substantial physiological 
differences between species.  
There are several limitations in using small animals to model a C. acnes associated PJI. 
First, mice and rabbits cannot maintain a C. acnes PJI the way it is maintained in humans, 
as their sebaceous glands contain little to no triglycerides that normally support C. acnes 
metabolism in humans.71 Second, mice and rabbits have historically co-evolved with a 
different set of resident microorganisms compared to humans and therefore have different 
joint microbiotas.72 C. acnes is known to interact with other microorganisms during 
infection processes like biofilm formation, so this discrepancy between species may 
engender misleading results. Third, there is no evidence to suggest that small animal 
joints have a similar degree of avascularity to larger human joint implants. Fourth, 
differences in immune responses between humans and small animals can drastically 
affect how infection progresses. There is evidence to suggest that C. acnes interacts with 
the host immune system, particularly with macrophages, during PJI.27,71 However, 
important human immune regulators may not be present in small animals, particularly in 
immunocompromised lab animals kept in a sterile environment. For example, memory 
CD8+ T cells – the first responders to infection – have been measured to be at nearly 
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undetectable levels in adult lab mice.73 This suggests that essential immune functions 
such as the foreign body response may be either missing or attenuated in small animals. 
In general, preclinical research done using animal models translate poorly in patients. It is 
predicted that only an estimated one-third of animal studies ever translate into human 
trials and one-tenth into clinical use in patients.74,75  
1.3.3 Ex vivo Models 
An ex vivo model is a system in which cells are isolated from their natural physiology and 
cultured under external laboratory conditions. Compared to animal models, an ex vivo 
model generally offers superior reproducibility since experiment parameters can be 
controlled. However, an ex vivo model also alters the cells’ natural environment, and key 
cellular responses and molecular interactions may be absent as a result. 
To date, several ex vivo models have been developed for investigating C. acnes-
associated PJIs. Most of these models are simple 2D bacterial growth assays designed to 
study the constituents of the C. acnes biofilm and the mechanisms of their formation.45,76 
Ex vivo models involving co-cultures of C. acnes and human cells have also been 
developed. For example, Aubin et al. used a simple broth culture assay to study gene 
expression changes in C. acnes following engulfment by osteoblasts and osteoclasts.77 
Fischer et al. used a similar system to assess the viability and proliferation of C. acnes 
following engulfment by THP-1 human monocytes/macrophages.78 
1.3.4 In vitro Models 
To our knowledge, there is currently no model of PJI designed to study the interactions 
between microbial pathogens and human connective tissue in a 3D environment that is 
representative of human joint physiology. Such a model would necessitate recreation of 
the joint-implant microenvironment under controlled laboratory settings.  
The joint capsule is mainly comprised of connective tissue (i.e. tendon, ligaments, bone, 
and cartilage). Given that the most abundant protein in connective tissue is collagen, and 
prosthetic encapsulation is solely a connective tissue process, a collagen-based model of 
PJI would likely provide a good degree of physiological relevance.79 Furthermore, the 
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polymerization of collagen would encapsulate cells within a 3D scaffold and engender 
multi-directional cellular interactions similar to those in 3D joint tissues.  
This thesis features the development of two novel 3D collagen-based in vitro models of 
C. acnes-associated shoulder joint infection, as well as their applications in furthering the 
understanding of PJI and the therapeutic interventions used to treat PJI.  
 
1.4 Objectives and Rationale 
Objective 1 
To profile global gene expression changes in human shoulder capsule (SC) fibroblasts 
and C. acnes in response to co-culture in a modified cell-populated collagen lattice 
system (figure 1.3). 
Objective 1 Rationale 
The cell-populated collagen lattice is a well-established 3D cell culture model routinely 
used for studying cellular behaviors and gene expression changes in monocultures of 
connective tissue cells, such as fibroblasts.80 We chose to expand the scope of this model 
to accommodate eukaryotic/prokaryotic cell co-cultures. Capsular fibroblasts from the 
shoulder joint are hypothesized to interact directly with C. acnes during PJI, so there is 
physiological relevance in mapping the gene expression changes in these cells. We 
anticipate this experiment will reveal key molecular pathways of the PJI process, as well 







Figure 1.3. Fibroblast-bacteria Co-culture in 3D Collagen (FBCC) model.  
(A) Patient-derived shoulder capsule fibroblasts were suspended in a collagen solution 
that polymerizes into a solid disc-shaped 3D lattice. (B) The collagen lattices were 
incubated in cell culture media under 5% CO2 and 37˚C, allowing fibroblasts to adjust to 
the 3D lattice environment. (C) Following a period of cell culture, the original media was 
replaced by fresh media containing an inoculum of Cutibacterium acnes. (D) The 
fibroblasts in collagen and C. acnes in media were incubated under hypoxic conditions 
(2% O2). (E) C. acnes in the media replicate and colonize the collagen surface, where 
they can interact with the immobilized fibroblasts. Following a period of co-culture, total 










To develop and optimize a 3D bioartificial human tissue model that can accurately 
recapitulate the microenvironment surrounding a surgical implant within an infected 
shoulder joint (The Shoulder Joint Implant Mimetic, figure 1.4). 
Objective 2 Rationale 
To our knowledge, the S-JIM is the world’s first in vitro model of PJI. It a system 
whereby cells are cultured under artificially created conditions designed to resemble their 
native joint environment. This model could provide a realistic preclinical landscape for 
the development of novel anti-PJI therapies, the screening of potential C. acnes-
associated biomarkers, and the validation of current clinical approaches to managing joint 
infection. The S-JIM is unique in that it supports a co-culture of anaerobic bacteria and 
soft bioartificial tissues created using patient-derived capsular fibroblasts. Unlike existing 
ex vivo models of PJI, including the FBCC, cells in the S-JIM are cultured in a 3D 
extracellular matrix with varying oxygen levels per layer. This is hypothesized to be 
representative of environment generated by periprosthetic tissues surrounding an implant. 
Compared to existing animal models of PJI, we anticipate the S-JIM will provide fewer 
technical challenges, allow for faster data generation, engender less experimental 
replication variability and bypass the complicated issue of translating research findings 




Figure 1.4. Shoulder-Joint Implant Mimetic (S-JIM) model.  
The S-JIM is a 3D in vitro cell culture system of C. acnes and primary SC fibroblasts 
derived from shoulder arthroplasty patients. (A) An implant mimetic was constructed by 
attaching a sheet of surgical titanium alloy onto a custom-designed mandrel. (B) SC 
fibroblasts were distributed into six collagen-impregnated cellulose scaffold strips and 
wrapped around the core of this mandrel in several successive layers to generate a 
cylindrical 3D bioartificial tissue construct. (C) This tissue construct was incubated under 
atmospheric oxygen levels, 5% CO2, at 37˚C. The growth of SC fibroblasts induced a 
decreasing oxygen accessibility gradient from the external to internal cell layers. (D) At 
various timepoints post-incubation, the strips of bioartificial tissue were unrolled, 
sectioned by circumferential layer, and subjected to fluorescence confocal microscopy 








To assess the effectiveness of vancomycin prophylaxis in C. acnes-associated 
periprosthetic joint infections using the newly developed S-JIM model. 
Objective 3 Rationale 
At present, clinical evidence for the prophylactic use of vancomycin in shoulder PJIs is 
weak due to the lack of controlled retrospective studies with complete datasets and 
adequate patient sample sizes. An in vitro system like the S-JIM can directly assess 
vancomycin’s bactericidal effectiveness under controlled parameters. Advantages of this 
system include the ability to model the delivery of vancomycin both in powder form and 
as an intravenous injection. 
 
Objective 4 
To determine a C. acnes-specific molecular target that can be used for microbial 
detection by desorption electrospray ionization mass spectrometry (DESI-MS) in the S-
JIM. 
Objective 4 Rationale 
Detecting C. acnes in a PJI is challenging due to the absence of routine inflammatory 
serum biomarkers. DESI-MS can potentially provide a rapid diagnosis of C. acnes within 
an infected joint, based on microbe-specific molecular targets. The first step in realizing 
DESI-MS as a point-of-care detection assay is to provide proof-of-principle for the 
existence of a C. acne specific molecular target that can reliably differentiate the bacteria 





2 MATERIALS AND METHODS 
2.1 Sample Collection 
2.1.1 Primary Human Fibroblasts 
Human shoulder capsule (SC) tissue offcuts designated “surgical waste” were excised 
from patients undergoing shoulder arthroplasties, de-identified and used for research 
purposes in accordance with Human Subject Research Ethics Board (HSREB) approval 
(#104888) at St. Joseph’s Health Care London, Canada. Tissue samples were dissected 
into ~1 mm fragments in a 10 mm petri dish using a scalpel and pair of tweezers. To 
facilitate the outgrowth of primary shoulder capsule (SC) fibroblasts, the tissue fragments 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 8% 
Gibco™ fetal bovine serum and a 1x Antibiotic-Antimycotic cocktail (100 units/mL of 
penicillin, 100 µg/mL of streptomycin, and 250 ng/mL of Gibco Amphotericin B) under 
standard conditions (37° C and 5% CO2). After 10 to 15 days, tissue fragments were 
removed and SC fibroblasts that adhered to the petri dish were detached using trypsin and 
transferred into a T75 flask. DMEM was replaced every 2-3 days and the cells were split 
in a 1:4 ratio at ~90% confluency every 5-10 days. SC fibroblasts that reached passages 3 
to 8 were detached using trypsin, centrifuged at 1500g, and resuspended in DMEM-soy 
media (DMEM supplemented with 8% fetal bovine serum and 0.4% soytone without the 
addition of antibiotics/antimycotics). These cells were used in downstream 3D co-culture 
experiments. 
2.1.2 Cutibacterium acnes 
C. acnes strains ATCC® 6919™ and ATCC® 11827™ were purchased from the 
American Type Culture Collection. C. acnes strain CA01 was isolated from the implant 
surface of a patient undergoing shoulder arthroplasty at St. Joseph’s Health Care London, 
Canada. All patient information was de-identified in accordance with HSREB restrictions 
under protocol #104888. All bacterial strains were stored in liquid nitrogen by flash-
freezing. Initial subcultures of C. acnes strains were grown in brain heart infusion media 
22 
under 0% O2, 5% CO2, and 37° C for 3 days prior to use in downstream applications. For 
experiments involving co-culture with SC fibroblasts, C. acnes was grown in DMEM-
soy. 
2.2 Fibroblast-bacteria Co-culture in 3D Collagen Setup 
Primary SC fibroblasts were cultured in fibroblast-populated collagen lattices, as 
described in Grinnell and Lamke (1984), with minor modifications in cell volumes and 
concentrations. Briefly, cells were grown in T75 culture flasks were detached using 
trypsin, centrifuged at 1500G, and resuspended in a 1:9 solution of 10x Waymouth media 
and Type I rat tail collagen (pre-warmed to ~25° C) at a concentration of 1.5 x 105 
cells/mL. 500 uL of this collagen-cell suspension was pipetted into each well of a 24-well 
tray and allowed to solidify for ~30 minutes in a 37° C cell culture incubator. 1 mL of 
DMEM supplemented with 8% fetal bovine serum was added to each well and the tray 
was returned to the incubator. After 72 hours, the original media was replaced by fresh 
media containing an inoculum of C. acnes at 5 x 106 bacteria/mL. Cells were cultured for 
48 hours in a hypoxic chamber (2% O2) at 37° C prior to collection. 
 
2.3 Shoulder-Joint Implant Mimetic Model Setup 
Primary SC fibroblasts grown in T75 culture flasks were detached using trypsin, 
centrifuged at 1500G and resuspended in a 1:9 solution of 10x Waymouth media and 
Type I rat tail collagen (pre-warmed to ~25° C) at a concentration of 2.5 x 106 cells/mL. 
200 uL of this collagen-cell suspension was pipetted into each trough of the strip casting 
tray (figure 4.1A) and immediately covered with strips of paper (dimensions 8 x 112 
mm) comprised of cellulose fibers (Miniminit, ON). The collagen-cell mixture in each 
trough was evenly distributed into the cellulose strips by rolling the cell spreader (figure 
4.1B) along the length of each trough. The strip casting tray containing the cell-infiltrated 
scaffolds was then transferred to a sealed sterile container and placed in a 37° C cell 
culture incubator for 30 minutes to allow for collagen polymerization. Polymerized strips 
were carefully removed from the strip casting tray using a pair of tweezers, transferred to 
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a six-well cell culture tray containing pre-warmed DMEM-soy media, and returned to 
incubate at 37° C for an additional 48 hours. 
Log-phase C. acnes was suspended in a 1:9 solution of 10x Waymouth media and Type I 
rat tail collagen (pre-warmed to ~25° C) at a concentration of 5.0 x 106 bacteria/mL and 
evenly distributed into an 8 x 17 mm cellulose scaffold strip using the same approach 
described above. This strip was wrapped around the titanium surface of the S-JIM 
mandrel (figure 4.1C) using the strip rolling tray (figure 4.1D) to generate a single-
layered coating of C. acnes. Six additional strips containing SC fibroblasts were wrapped 
in succession around the S-JIM mandrel. The wrapped biocomposite mandrel was placed 
in the well of a six-well tray containing 10 mL of DMEM-soy media and incubated for 96 
hours under 5% CO2 at 37°C. 
In S-JIM experiments involving the direct application of vancomycin, ~50 mg of 
vancomycin hydrochloride powder (McGuff Medical Products) was directly applied on 
top of the C. acnes-containing scaffold strip prior to wrapping. In S-JIM experiments 
modelling the intravenous application of vancomycin, wrapped S-JIM mandrels were 
cultured in media containing vancomycin at concentrations of 5 and 20 μg/mL, 
representing the clinical consensus for the initial and trough serum concentrations during 
infection prophylaxis.81,82 After 96 hours of incubation, all strips were unwrapped and the 
C. acnes-containing strip was briefly vortexed in 10 mL of DMEM-soy media. An 
aliquot (100 μL) of this media was spread onto a brain heart infusion agar plate and 
cultured anaerobically for 7 days, after which the number of colony-forming units were 
calculated.  
 
2.4 Desorption Electrospray Ionization Mass Spectrometry 
DESI-MS imaging was performed on a Quadrupole-Time-of-Flight Mass Spectrometer 
(Xevo G2-XS, Waters), using a solvent mixture of 95:5 methanol:water, spiked with 
150pg/µL of Leucine Enkephalin, at a flow rate of 1µL/min. All data was collected in the 
negative ion mode over a mass range of m/z 100-1000, with a voltage of 4.2kV applied to 
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the spray, a nebulizer gas pressure of 72psi and an ion block temperature of 150°C. S-
JIM strips, embedded with C. acnes and/or SC fibroblasts according to the S-JIM 
protocol, were taped to glass microscope slides and experimental samples were smeared, 
using a plastic pipette tip, directly on top of each strip as well as on a blank slide. Strips 
were left to dry prior to analysis. Slides were then placed on a 2D translational stage in 
front of MS inlet and rastered underneath the solvent spray at a rate of 100µm/s. Images 
were generated using High Definition Imaging software (Waters) at a resolution of 
100µm×100µm. All DESI-MS handling and analysis were performed by the Zarrine-
Afsar lab from the University Health Network, Toronto, Canada. 
 
2.5 Quantification of Gene Expression 
2.5.1 RNA Extraction from FPCL Samples 
FPCL samples were excised from the culture tray using a scalpel and submerged in a 1:1 
volume of TRIzol™ Reagent. Samples were incubated at room temperature for ~2 hours 
until all visible collagen-cell fragments were dissolved. The resulting suspension was 
needle aspirated thrice to ensure complete lysis of cell membranes. RNA was isolated 
using the Direct-zol RNA MiniPrep kit (Zymoresearch) according to the manufacturer’s 
instructions. 
2.5.2 RNA Extraction from S-JIM Samples 
S-JIM strips were unraveled from the mandrel using a pair of tweezers and sectioned by 
their circumferential layer during culture. Each strip section was submerged in 500 μL of 
TRIzol™ Reagent and repeatedly vortexed for ~15 seconds at 30 minute intervals over ~ 
2 hours. S-JIM strips were subsequently removed, and RNA was isolated using the 
Direct-zol RNA MiniPrep kit (Zymoresearch) according to the manufacturer’s 
instructions. 
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2.5.3 cDNA Synthesis 
Total RNA concentration and quality (A230:260 and A260:280) were determined using a 
NanoDrop-1000 spectrophotometer (Thermofisher Scientific). 200 ng to 1 μg of total 
RNA was reverse transcribed into cDNA using the High-Capacity cDNA Reverse 
Transcription Kit (Thermofisher Scientific) according to the manufacturer’s instructions. 
2.5.4 Real Time PCR 
cDNA was diluted two-fold in RNAse/DNase-free water and 4.5 μL of this dilution was 
loaded in triplicate into MicroAmp Optical 384-well reaction plates (Life Technologies). 
TaqMan gene expression assays (Life Technologies) were used to measure expression of 
genes of interest in accordance with the manufacturer’s instructions. All gene expression 
levels were assessed relative to expression of the “housekeeping” gene RPLP0 (encoding 
Ribosomal Protein Lateral Stalk Subunit P0), as it displayed the least degree of variability 
across treatment groups. PCR reactions were carried out for 40 cycles of denaturation 
(95°C for 1 second) and annealing/extension (60°C for 20 second). Relative 
quantification was calculated using the ΔΔCt method. 
2.5.5 Statistical Analysis 
Statistical analysis was conducted using Prism8 (GraphPad) software. Ordinary one-way 
ANOVA with Tukey’s multiple comparisons test was used to identify significant gene 
expression changes in SC fibroblasts cultured with and without C. acnes. Statistical 
significance between grouped means is indicated as follows: * p < 0.05, ** p < 0.01, *** 
p < 0.001. All error bars represent a 95% confidence interval in which the true mean of 
the dataset is represented for each experimental condition. 
2.5.6 RNA Sequencing 
RNA quality (A260/280 and A260/230 values between 1.8 and 2.0) and yield (>100 ng/µL) 
were confirmed for all experimental samples using the Agilent 2100 Bioanalyzer. From 
each sample, ribosomal RNA was isolated from 1.0 µg of total RNA and RNA libraries 
were prepared using the Illumina NextSeq Mid Output Kit (Vazyme VAHTS Total RNA-
seq (H/M/R) Library Prep Kit for Illumina®). The resulting RNA libraries were 
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sequenced using the NextSeq 550 System and the RNA library preparation was analyzed 
using Partek Flow® data analysis software. In brief, raw sequencing reads were aligned 
to the human reference genome (hg38) using the Spliced Transcripts Alignment to a 
Reference (STAR) tool. The aligned reads were screened for noise at a minimum 
threshold of 50 reads/gene and normalized by Counts Per Million (CMM + 1). 
Differential analysis of gene expression was performed using Gene Specific Analysis 
(GSA). Inclusion criteria for downstream analysis consisted of p ≤ 0.01 and fold-change 
in gene expression of ≥ 2.0 or ≤ -2.0. All heat-maps, gene set enrichment, and pathway 
enrichment data were generated using internal Partek Flow® data analysis software. 
 
2.6 S-JIM Cell Imaging 
2.6.1 EF5 Hypoxia Labelling 
Sixteen hours prior to staining, EF5 – a small molecule with hypoxia-inducible cell 
binding affinity – was added to the S-JIM cell culture media to a final concentration of 
100 μM. S-JIM strips were unraveled from the mandrel using a pair of tweezers, 
sectioned by their circumferential layer during culture, and immediately fixed in 4% 
paraformaldehyde for 10 minutes. Following fixation, section samples were 
permeabilized by 0.2% Triton X for 20 minutes, blocked with 5% bovine serum albumin 
and stained with 25 µg/ml Cy3-conjugated anti-EF5 antibody (Millipore Sigma) at 4° C 
overnight. All samples were washed thrice in phosphate-buffered saline (PBS) buffer for 
5 minutes after each of the abovementioned steps. Processed samples were imaged using 
a A1R HD25 confocal microscope (Nikon Imaging). 
2.6.2 Live-Dead Mammalian Cell Labeling 
S-JIM strips were unraveled from the mandrel using a pair of tweezers, sectioned by their 
circumferential layer during culture, and washed briefly in PBS. Section samples were 
then stained with 3 μM calcein-AM (live stain) and ethidium homodimer-1 (dead stain) 
for 20 minutes, washed briefly in PBS, and imaged using a A1R HD25 confocal 
microscope (Nikon Imaging). 
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2.6.3 Scanning Electron Microscopy 
Titanium foil samples were carefully removed from the S-JIM mandrel following cell 
culture and immersed in 2.5% glutaraldehyde constituted in Sorensen’s buffer (16 mM 
KH2PO4 + 117 mM Na2HPO4, pH = 6.0). Samples were fixed for 2 hours at room 
temperature and washed 3 times with Sorensen’s buffer (5 minutes per wash). Follow 
fixation, samples were initially dehydrated in progressively higher concentrations of 
ethanol (25% → 50% → 70% → 90% → 100%) and further dehydrated in 
hexamethyldisilazane before being processed in a critical point dryer. Once completely 
desiccated, samples were mounted on carbon‐taped aluminum stubs and gold/palladium‐
sputtered at 15 mA for 4 minutes. All imaging and image analysis were performed using 
a Hitachi S-3400N with the assistance of Karen Nygard and Reza Khazaee from the 







3 FIBROBLAST-BACTERIA CO-CULTURE IN 3D 
COLLAGEN (FBCC) 
3.1 Validation of Model and Suitable Housekeeping Gene in 
SC Fibroblasts Following Co-culture with C. acnes 
The impact of C. acnes on the gene expression of human shoulder fibroblasts has not 
been previously studied, despite the proximity of these cells in an infected joint capsule. 
The FBCC model was developed for real time PCR (methods 2.5.4) and RNA 
sequencing analyses (methods 2.5.6) of gene expression changes in SC fibroblasts 
following co-culture with C. acnes in a 3D collagen lattice (methods 2.2). 
All experiments involving the FBCC model were conducted under 2% O2 as the hypoxic 
environment is representative of the post-operative shoulder joint and enables the 
proliferation of C. acnes and SC fibroblasts. We selected 24 and 48 hours as the co-
culture durations as the C. acnes strains achieved in vitro log-phase growth during this 
timeframe (figure 3.1). Three C. acnes strains – ATCC 6919, ATCC 11827 (dermally-
derived isolates), and CA01 (patient-derived biopsy from the site of shoulder PJI) – were 






Figure 3.1. In vitro Growth Curve of C. acnes.  
The growth of C. acnes strains CA01 and ATCC 11827 was monitored under 0%, 2%, 
and 21% oxygen cell culture conditions over 96 hours. Each datapoint represents an 











Given that this is the first reported co-culture experiment involving C. acnes and SC 
fibroblasts, reference gene(s) that were previously determined to exhibit stable expression 
in human cells had to be revalidated to rule out the possibility of interference with C. 
acnes transcripts. The expression of three housekeeping genes were evaluated – RPLP0 
(Ribosomal Protein Lateral Stalk Subunit P0), GAPDH (Glyceraldehyde 3-phosphate 
dehydrogenase), and ACTB (Beta-actin) – for their suitability to serve as reference genes 
in our real-time PCR experiments. In theory, the expression of a housekeeping gene 
should remain constant across all treatment and control conditions. However, the 
expression of GAPDH, ACTB, and RPLP0 varied significantly relative to one another in 
SC fibroblasts cultured with and without C. acnes (figure 3.2A). 
To determine the gene with the smallest change in expression between experimental and 
control conditions, the consistency in cycle threshold values was assessed for the three 
genes (figure 3.2B). RPLP0 showed the smallest range and variation of cycle thresholds, 
indicating it was expressed at more consistent levels across control and treatment groups. 
This result was later confirmed by RNA sequencing, which revealed RPLP0 gene 
expression did not change significantly in SC fibroblasts cultured with and without C. 
acnes. Conversely, GAPDH and ACTB gene expression were upregulated by 2.59-fold 
and downregulated by 6.26-fold respectively by the presence of C. acnes. The real time 
PCR and RNA sequencing results were consistent with these data. Thus, the expression 
of all target genes was normalized to RPLP0 for evaluating differential expression 






Figure 3.2. Evaluating suitable SC fibroblast housekeeping genes.  
(A) The range of cycle thresholds (Ct) from all treatment and control groups were plotted 
for three putative housekeeping genes RPLP0; GAPDH, Glyceraldehyde 3-phosphate 
dehydrogenase; ACTB, Beta-actin. Boxes indicate the interquartile range and capped 
lines indicate the full range of Ct values. (B) Gene expression of SC fibroblasts co-
cultured with C. acnes strains CA01, ATCC 11827, and ATCC 6919 in the FBCC system 
was normalized to the expression of RPLP0, Ribosomal Protein Lateral Stalk Subunit P0. 
Significant differences between groups are denoted as *p < 0.05, **p < 0.01, and ***p < 
0.001. All experiments were performed in triplicate (n = 3). Error bars indicate 95% 










3.2 Impact of C. acnes on SC Fibroblasts Gene Expression 
Having established RPLP0 as a suitable reference gene, it was possible to assess the 
impacts of C. acnes co-culture on SC fibroblast gene expression and determine if these 
connective tissue cells could detect the presence of C. acnes under in vitro conditions.  
The first step was to assess the expression of genes involved in regulating inflammation, 
as common inflammatory biomarkers are oftentimes not detected in a C. acnes PJI58,59 
despite inflammation being a general characteristic of microbial infection. The gene 
expression of the pro-inflammatory cytokines PTGS2 (Prostaglandin-Endoperoxide 
Synthase 2), TNF (Tumor Necrosis Factor), IL6 (Interleukin 6), and CCL2 (C-C Motif 
Chemokine Ligand 2) were reportedly upregulated in prostate epithelial cells in in vitro 
co-culture with C. acnes.83,84 Conversely, the gene expression of IL10 (Interleukin 10), an 
anti-inflammatory cytokine, was reportedly downregulated in this simple co-culture 
model. We chose to investigate the gene expression changes in these cytokines given that 
they were previously reported to respond to C. acnes, and are key regulators of the 
inflammation response response pathway.85–88 
The real time PCR data (methods 2.5.4) indicated a significant increase in PTGS2 
expression and decrease in IL10 expression in SC fibroblasts after 24 and 48 hours of co-
culture with C. acnes. TNF expression only increased after 48 hours. For these three 
genes, changes in expression were more robust at 48 hours compared to 24 hours, 
indicating the increased sensitivity of SC fibroblasts to C. acnes at the longer timepoint. 
Conversely, IL6 expression increased after 24 hours but returned to baseline after 48 
hours, and CCL2 expression was unchanged after 24 hours but downregulated after 48 
hours. The inconsistency of IL6 and CCL2 transcript levels at 24 and 48 hours may be 
due to temporal regulation of gene expression. Overall, the data were interpreted as 






Figure 3.3. C. acnes elicits an in vitro inflammatory response in SC fibroblasts.  
Gene expression of SC fibroblasts co-cultured with C. acnes strains CA01, ATCC 11827, 
and ATCC 6919 in the FBCC system after (A) 24 hours and (B) 48 hours was normalized 
to the expression of RPLP0. Significant differences between treatment groups are 
denoted as *p < 0.05, **p < 0.01, and ***p < 0.001. All experiments were performed in 
triplicate (n = 3). Error bars indicate 95% confidence intervals. PTGS2, Prostaglandin-
Endoperoxide Synthase 2; TNF, Tumor Necrosis Factor; IL6, Interleukin 6; CCL2, C-C 
Motif Chemokine Ligand 2; IL10, Interleukin 10. 
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Next, the gene expressions of TLR2 (Toll-like Receptor 2) TLR3 (Toll-like Receptor 3), 
and TLR4 (Toll-like Receptor 4) were assessed to determine whether SC fibroblasts can 
detect the presence of C. acnes on a molecular level (figure 3.4). The gene expression of 
receptor(s) that can specifically detect C. acnes was expected to increase given that 
cellular responses to infection generally involves an amplification in the infection 
signaling cascade. TLR2 recognizes a broad range of substrates from bacterial cell walls, 
TLR3 recognizes dsRNA viruses and TLR4 recognizes lipopolysaccharides found on 
gram-negative bacteria (C. acnes is gram-positive).89 A ~5 fold increase was observed for 
TLR2 expression, whereas a ~5 to 10 fold decrease was observed for TLR3 and TLR4 
expression after 48 hours of culture.  
C. acnes infection has been shown to inhibit wound repair processes like ECM formation, 
so the expression of genes involved in extra-cellular matrix (ECM) formation – HAS3 
(Hyaluronan Synthase), COL1A1 (Collagen Type I Alpha 1 Chain), COL3A1 (Collagen 
Type III Alpha 1 Chain) – were assessed. All three genes were significantly 
downregulated in SC fibroblasts after 48 hours of co-culture with C. acnes (figure 3.5).  
The real-time PCR analyses of gene expression demonstrated that multiple cellular 
processes in SC fibroblasts react to the presence of C. acnes. However, the analyses only 
observed a small subset of genes involved in these cellular processes and may not be 
representative of the overall response. It was also unclear whether downregulation of 
extracellular matrix genes (COL1A1, COL3A1, and HAS3) and toll-like receptor genes 
(TLR2 and TLR4) were the result of specific signaling pathways induced by C. acnes or a 







Figure 3.4. Expression of toll-like receptor genes are suppressed in SC fibroblasts 
following co-culture with C. acnes.  
Gene expression of SC fibroblasts co-cultured with C. acnes strains CA01, ATCC 11827, 
and ATCC 6919 in the FBCC system after 48 hours was normalized to the expression of 
RPLP0. Significant differences between treatment groups are denoted as *p < 0.05, **p < 
0.01, and ***p < 0.001. All experiments were performed in triplicate (n = 3). Error bars 
indicate 95% confidence intervals. TLR2, Toll-like Receptor 2; TLR3, Toll-like Receptor 











Figure 3.5. Expression of extracellular matrix genes are suppressed in SC 
fibroblasts following co-culture with C. acnes.  
Gene expression of SC fibroblasts co-cultured with C. acnes strains CA01, ATCC 11827, 
and ATCC 6919 in the FBCC system after 48 hours was normalized to the expression of 
RPLP0. Significant differences between treatment groups are denoted as *p < 0.05, **p < 
0.01, and ***p < 0.001. All experiments were performed in triplicate (n = 3). Error bars 
indicate 95% confidence intervals. COL1A1, Collagen Type I Alpha 1 Chain; COL3A1, 











3.3 Net Changes in SC Fibroblast Gene Expression in 
Response to a C. acnes Infection 
To gain a genome-wide perspective of gene expression changes induced by C. acnes, a 
transcriptomic profile was generated for SC fibroblasts, using the RNA sequencing 
approach described in methods 2.5.6. SC fibroblast cultures from three different 
arthroplasty patients (N = 3), and two C. acnes strains – ATCC 11827 and CA01 – were 
included in this experiment.  
Total extracted RNA was processed by the London Regional Genomics Centre. In brief, 
eukaryotic rRNA was depleted, the remaining mRNA and other transcripts were reverse 
transcribed, sequenced, and aligned to a human reference genome (hg38 - Ensembl 
Transcripts release 99). Raw transcript reads collectively aligned to 15,860 genes from 
the human genome, with the expression of 4889 genes being significantly altered (p < 
0.01) by at least a factor of 2 between SC fibroblasts cultured with C. acnes and SC 
fibroblasts cultured without C. acnes. The media pH and oxygen concentration were kept 
constant at pH = 7 and 2% O2 in the FBCC system during co-culture.  
A heatmap of significant gene expression changes (p < 0.01) was generated to visualize 
differential expression profiles across the experimental samples (figure 3.6). The nine 
experimental samples were sorted into two main groups – SC fibroblasts cultured with C. 
acnes and SC fibroblasts cultured without C. acnes – thereby confirming the most 
significant cause of differential gene expression to be the presence of C. acnes.  
Most of the differentially expressed genes in SC fibroblasts (77%) were downregulated 
following co-culture with C. acnes (figure 3.6). To confirm this, a list of 22 significantly 
altered cellular pathways (p < 0.01) was generated by clustering differentially expressed 
genes by function (Table S1). Twenty of these pathways convincingly showed a net 
decrease in gene expression activity, thereby supporting our previous observation of gene 
expression repression mechanism(s). The two pathways that appeared to reflect a net 
increase in activity were the pro-inflammatory TNF and IL-17 signaling pathways 
(figure S1). In both pathways, genes encoding membrane receptors and intermediate 
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signaling molecules were downregulated whereas the downstream transcriptional target 


















Figure 3.6. Heatmap of differentially expressed mRNA in SC fibroblasts cultured in 
the FBCC model with or without C. acnes.  
The mean signal intensities for mRNAs exhibiting p < 0.01 are shown following 
normalization and Z-transformation. Green and red bars represent upregulation and 
downregulation in gene expression relative to Z-score of 0. Samples used in this analysis 
include three primary SC fibroblast cell cultures derived from different arthroplasty 
patients (SC1, SC2, SC3) and two C. acnes strain (11827 and CA01). The percentage of 
genes that were upregulated (23%) and downregulated (77%) with the addition of C. 








4 Shoulder-Joint Implant Mimetic (S-JIM) 
4.1 Model Development and Optimization 
The FBCC model is a simple and efficient co-culture system for studying gene 
expression changes in human fibroblasts during a C. acnes PJI. However, the FBCC 
model does not reflect the oxygen gradient that would be present across connective 
tissues in a real PJI, given the entire system is kept in a consistent 2% O2 environment. 
Furthermore, the FBCC model does not include the presence of an implant mimetic, 
which is required to initiate a C. acnes PJI in mice models. These two limitations of the 
FBCC model may result in unrepresentative cellular responses to a C. acnes PJI.  
The S-JIM model was developed to provide a 3D cell culture environment that is more 
physiologically-representative for the study of PJI. The S-JIM design was adapted from 
the TRACER cell culture system (Tissue Roll for Analysis of Cellular Environment and 
Response).90 TRACER was originally developed to model tumor behavior under hypoxic 
conditions. In brief, tumor cells are seeded onto a scaffold strip and rolled around a 
mandrel core, forming multiple layers of an artificial “3D tumor”. As this “tumor” is 
cultured, oxygen diffuses through the strips and are progressively metabolized by cells 
from each successive layer. This generates a gradient of oxygen levels across the outer 
and inner strip layers, from normoxic to hypoxic cellular environments.90,91 
The aim of this project was to cross-purpose the TRACER system into a model of 
infection by modifying several steps from the original protocol (Table 4.1). The process 
of S-JIM optimization involved several iterations of trial and error. In brief, there were 
four key considerations in making alterations to the original TRACER protocol: 
1. Enabling efficient model setup to increase reproducibility between replicates. 
2. Generating an oxygen accessibility gradient across S-JIM layers, with a near-
anaerobic inner core to support C. acnes proliferation. 
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3. Creating a microenvironment for adjacent C. acnes and SC fibroblasts to interact. 
4. Inducing C. acnes biofilm formation on the metallic surface of the S-JIM core to 
mimic infection of a prosthetic implant. 
4.2 Custom S-JIM Assembly Tools 
A set of 3D-printed cell culture tools was developed to enable efficient and consistent S-
JIM setup (figure 4.1). The strip casting tray provided a platform for the distribution of 
cells and collagen into the S-JIM strips. Rapid and even cell seeding distribution was 
achieved by rolling a cell spreader along the strip length. S-JIM mandrels were designed 
with a threaded lid and a mandrel base that allowed them to be screwed together into a 
single unit. This design allowed for easy assembly and removal of coiled metallic foils 
from the mandrel surface. Scaffold strips were cut to a width of 8 mm to match the 
mandrel core length and to prevent oxygen leakage from the sides of the mandrel. A 













Table 4.1. Modifications to Cell Culture Parameters and Model Setup from the 
TRACER to S-JIM System. 
Parameter TRACER S-JIM 
Human cell seeding density 1.0 x 107-8/mL collagen 2.5 x 106/mL collagen 
C. acnes seeding density NA 5.0 x 106/mL collagen 
Number of strips per mandrel 1 6 
Number of cell-strip layers 6 ~25 
Strip size 5 x 120 mm 8 x 112 mm 












Figure 4.1 Custom-designed cell culture tools for S-JIM setup.  
The strip casting tray (A) was molded from polydimethylsiloxane (PDMS) – a soft but durable silicon-
based polymer with hydrophobic properties. It contains several surface troughs (100 µm deep) that allow 
collagen-cell suspensions to be evenly distributed onto cellulose scaffold strips using a cell spreader (B). 
The S-JIM mandrel (C) is comprised of a base and an attachable lid, both of which have a hexagonally 
hollow core parallel to the axis. A single-layer coil of titanium alloy is first secured onto the thinner section 
of the mandrel base before the lid is re-attached to keep the metal in place. The mandrel is then skewered 
between the bases of the strip rolling tray (D) using a hexagonal screwdriver, whereby rotation of the 
handle facilitates rapid wrapping of cell-embedded scaffold strips around the mandrel core. All custom-
designed tools withstand repeated sterilization by 70% ethanol. All tools aside from the strip casting tray 









4.3 Generating an Oxygen Accessibility Gradient Across S-
JIM Strip Layers 
The human connective tissue surrounding a joint capsule is comprised of several layers, 
and the difference in vascularity between these layers generates a gradient of oxygen 
accessibility. Given that anaerobes like C. acnes preferentially proliferate in hypoxic 
conditions (figure 3.1), the differences in oxygen availability across these tissue layers 
may contribute to the progression of PJI.  
To incorporate this consideration in the S-JIM model, an oxygen availability gradient 
between ~0% to 21% was generated across the cell-strip layers (figure 4.2A). In brief, 
SC fibroblasts were mixed with collagen and even distributed into the S-JIM strip at 
different seeding densities, in the absence of C. acnes. Oxygen levels at individual layers 
were assessed by gene expression analyses of HIF1A and its downstream transcriptional 
target, DDIT3 (methods 2.5.2). However, significant differences in oxygen levels were 
not observed in experiments with initial cell seeding densities between 1.5 x 105 to 2.5 x 
106 cells/mL collagen. Increasing the cell density beyond 2.5 x 106 cells/mL collagen was 
not feasible due to the time and material costs associated with culturing a large quantity 
of slow-growing primary fibroblasts. Furthermore, SC fibroblasts were larger than tumor 
cells in the TRACER model (~50 µm in diameter compared to ~10 to 20µm) and 
therefore occupied more space in the S-JIM strips. 
To increase the contrast in oxygen availability between the inner and outer “tissue” layers 
in the S-JIM, five additional strips were wrapped around the S-JIM to increase the 
thickness of the biocomposite mandrel and lower the rate of oxygen diffusion. The 
additional strips engendered ~25 layers in the S-JIM, in contrast to the 6 layers in the 
TRACER model. Under these conditions, gene expression analyses of SC fibroblasts in 
the S-JIM indicated significantly elevated levels of HIF1A and DDIT3 in the inner strip 
layers relative to outer layers (figure 4.2B). This data is consistent with a decreasing 
oxygen accessibility gradient from the exterior to interior layers. Oxygen levels in SC 
fibroblasts were further assessed by staining with EF5 – a synthetic compound that 
preferentially binds to cells in hypoxic conditions. Following incubation with an anti-EF5 
cyanine 5 conjugate, the fluorescence intensity in these cells was assessed by confocal 
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microscopy (methods 2.6.1). SC fibroblasts from the inner S-JIM layers exhibited higher 
fluorescence readings compared to the outer layers (figure 4.2C). This data is consistent 














Figure 4.2. Gradient of oxygen levels in the S-JIM.  
(A) Theoretical depiction of an oxygen gradient generated by the S-JIM. (B) Gene 
expression analyses of HIF1A, Hypoxia Inducible Factor 1 Alpha and its downstream 
transcriptional target DDIT3, DNA Damage Inducible Transcript 3 in SC fibroblasts were 
analyzed in the absence of C. acnes (n = 3). Error bars indicate 95% confidence interval 
range. * p < 0.05, *** p < 0.001 (C) SC fibroblasts in the six S-JIM strips were stained 
with EF5 – a hypoxia probe (red) – and DAPI (blue). Intensity of EF5 signal correlates 
qualitatively with the relative hypoxia in the cellular environments. Cell-strip controls 





4.4 C. acnes Induces SC Fibroblast Cell Death  
Connective tissue necrosis is one of the hallmarks of PJI. To assess the impact of C. 
acnes on the viability of the S-JIM “tissue” layers, SC fibroblasts were labelled with 
calcein and ethidium homodimer-1. Calcein is a membrane-permeable fluorescein that is 
activated by intracellular esterase activity and ethidium homodimer-1 is a membrane-
impermeable DNA intercalator agent. Only live cells that possess functionally active 
esterases and intact cellular and nuclear membranes would be labelled with calcein. 
Conversely, dead or dying cells with no esterase activity and partially lysed cellular and 
nuclear membranes would be labelled with ethidium homodimer-1.  
Calcein and ethidium homodimer-1 labelled SC fibroblasts were imaged by confocal 
microscopy (methods 2.6.2). After 96 hours of co-culture with C. acnes, SC fibroblasts 
from the core S-JIM layers (1 and 2) were predominantly labelled with ethidium 
homodimer-1, and SC fibroblasts from the outer S-JIM layers (7 and beyond) were 
predominantly labelled with calcein (figure 4.3A). SC fibroblasts in the no bacteria 
control were predominantly labelled with calcein across all S-JIM layers, thereby 
confirming that cell viability was not influenced by differences in media and oxygen 
accessibility between the S-JIM layers (figure 4.3B). These results demonstrated that C. 
acnes induces SC fibroblasts cell death, and thereby the necrosis of connective tissue 




Figure 4.3. C. acnes Induces SC Fibroblast Cell Death 
Six biocomposite strips embedded with SC fibroblasts were subjected to live-dead staining analyses after 
96 hours of incubation in a S-JIM in the presence (A, C) or absence (B, D) of C. acnes. Live SC fibroblasts 
are labelled with calcein (green) – a cell-permeable dye that is converted to a fluorescent form via 
intracellular esterase activity. C. acnes and dead SC fibroblasts are labelled with the DNA intercalator 
ethidium homodimer-1 (red). Strip sections are labelled by their respective layer around the S-JIM mandrel, 






4.5 C. acnes Grows on Titanium Alloy Surfaces in an S-JIM 
but Does Not Form a Biofilm  
To determine how C. acnes interacts with an implant during PJI, C. acnes was co-
cultured with SC fibroblasts in the S-JIM, and the Ti6Al4V titanium-alloy surface of the 
mandrel core was imaged by scanning electron microscopy (methods 2.6.3). Individual 
C. acnes cells appeared to form aggregates on the foil surface after 96 hours, but these 
cells were not encapsulated in an EPS matrix (figure 4.4). 
Given that C. acnes biofilm formation is routinely observed in mouse models52, and that 
these biofilms consist of an extracellular polymeric matrix, several attempts were 
undertaken to promote C. acnes biofilm formation in the S-JIM. The first step involved 
assessing C. acnes biofilm formation on a flat Ti6Al4V surface in the absence of SC 
fibroblasts. When C. acnes was cultured anaerobically in DMEM-soy (the same media 
used in the S-JIM), cell aggregates were once again observed on the Ti6Al4V surface in 
the absence of a biofilm matrix. However, when DMEM-soy was replaced with BHI (a 
routine microbial growth media), C. acnes cells appeared to be encapsulated in a gel-like 
EPS matrix. This matrix was also observed when C. acnes was cultured in a 1:1 media 
combination of DMEM-soy and BHI (figure 4.5A). These results indicate that BHI is at 
least in part necessary for C. acnes biofilm formation. However, when BHI or the 1:1 
media combination of DMEM-soy and BHI was used to co-culture C. acnes with SC 
fibroblasts in the S-JIM, the EPS matrix was no longer observed. 
Additional attempts to generate a C. acnes biofilm matrix included diluting the media 
concentration to promote a “starved” microbial state (figure 4.5B), supplementing the 
culture media with human serum to increase the concentration of coagulant factors in the 
media (figure 4.5C), and increasing the surface roughness of the Ti6Al4V foils to 
promote bacterial adherence (figure 4.5D). However, no convincing evidence of EPS 




Figure 4.4. C. acnes Growth on Ti6Al4V Titanium Alloy Foils in the S-JIM. 
Scanning electron microscopy images of C. acnes growth on Ti6Al4V foils after 96 hours of co-culture 
with SC fibroblasts in the S-JIM. Imaging was performed with assistance from the Integrated Microscopy 





Figure 4.5. C. acnes aggregates on the surface of Ti6Al4V titanium-alloy foils.  
(A) Scanning electron images of C. acnes CA01 on Ti6Al4V titanium-alloy foils cultured in DMEM-soy 
media, BHI media, and an even mixture of the two for 96 hours. (B) C. acnes was cultured for 48 hours 
with DMEM-soy media, and then for an additional 48 hours in DMEM diluted with an appropriate volume 
of phosphate-buffered saline. (C) C. acnes was cultured in DMEM-soy media supplemented with 20% 
human serum. (D) C. acnes was cultured in DMEM-soy media on a Ti6Al4V foil with an unaltered surface 
(smooth) and one that has been treated with sandpaper (rough). Imaging was performed with the assistance 









4.6 Identifying Putative Biomarkers of C. acnes PJI 
Detecting C. acnes in PJIs remains a clinical challenge due to the slow progression of 
infection and the lack of reliable serum biomarkers. We previously identified a list of SC 
fibroblast genes that were significantly upregulated in the presence of C. acnes using the 
FBCC system. Several of these genes were hypothesized to be potentially novel 
biomarkers of C. acnes PJI, as they encode secreted proteins that may potentially be 
detectable in periprosthetic tissues or blood serum. Four of these genes – Stanniocalcin-1 
(STC1), Angiopoietin-like 4 (ANGPTL4), Carboxypeptidase A4 (CPA4), and Neuron 
derived neurotrophic factor (NDNF) – were selected for further investigation using the S-
JIM model, as their roles in microbial infection is currently unknown.  
The changes in gene expression were confirmed by real time PCR (methods 2.5.2). In 
general, the expression of all four genes appeared to be higher in the innermost layers (1, 
3, and 5) compared to the outermost layer (20). STC1 and CPA4 transcript levels 
appeared highest in the innermost layer that was in contact with C. acnes, whereas 
ANGPTL4 and NDNF transcript levels appeared highest in layer 3 (figure 4.6). This 
finding may be reflective of either temporal gene expression regulation or C. acnes-
induced cell death in the innermost layer.  
Additionally, all four fibroblast genes exhibited significantly enhanced expression in SC 
fibroblasts from layers 1 to 3 when C. acnes was present in the S-JIM. This increase in 
gene expression was less significant in layer 5, and absent in layer 20 (the outermost 
layer), presumably due to the absence of C. acnes at the higher oxygen levels. While the 
present data cannot confirm whether direct or indirect contact with C. acnes was 
responsible for these gene expression changes, it does illustrate all four putative 
biomarkers were upregulated by the presence of C. acnes in the S-JIM, consistent with 






Figure 4.6. Putative SC Fibroblast Biomarker Gene Expression Changes in 
Response to C. acnes in the S-JIM.  
S-JIMs were set up according to the optimized protocol (methods 2.3). Relative mRNA 
levels in S-JIM layers 1 (innermost), 3, 5, and 20 were assessed by real time PCR and 
normalized to RPLP0. All experiments were performed in triplicates (n = 3). STC1, 
Stanniocalcin-1; ANGPTL4, Angiopoietin-like 4; CPA4, Carboxypeptidase A4; NDNF, 
Neuron derived neurotrophic factor. Error bars indicate 95% confidence interval range. 
Significant differences in gene expression between the CA01 condition and no C. acnes 






4.7  Applications of the Shoulder-Joint Implant Mimetic 
4.7.1 Overview 
Given that the S-JIM is a newly developed model, it was necessary to confirm its 
reproducibility and preclinical validity. Two studies related to the detection and 
prevention of C. acnes-associated shoulder PJIs were selected for investigation using the 
S-JIM.  
1. Evaluating the prophylactic benefit of vancomycin treatment against C. acnes 
during shoulder arthroplasty. 
2. Confirming the prospective use of desorption electrospray ionization mass 
spectrometry as a point-of-care diagnostic assay for C. acnes PJIs. 
4.7.2 Validation of Vancomycin Prophylaxis in C. acnes PJI 
Vancomycin is often considered a first-choice drug for postoperative infection in 
orthopedics as it is effective against commonly-encountered staphylococci species.92 
However, the clinical benefit of using vancomycin in C. acnes-associated shoulder PJIs is 
currently unclear, as the number of PJI patients in most hospitals is generally too low to 
provide statistically significant data. The cost of vancomycin is not a prohibitive factor93, 
but a prolonged trough serum concentration above 15 – 20 μg/mL can increase the risk of 
renal function deteroriation.19 The goal of this study was to evaluate the bactericidal 
effectiveness of vancomycin treatment against C. acnes in the S-JIM model. 
The first step was to assess the functional activity of vancomycin in the presence of 
human fibroblasts, as it was unclear whether these cells could clear, degrade, or 
chemically alter the antibiotic. To do so, changes in vancomycin concentration were 
extrapolated from disc diffusion assays following incubation with SC fibroblasts, as 
described in figure 4.7A. There was no statistical difference between the zones of 
inhibition radii of vancomycin that was incubated with SC fibroblasts (blue line) and 
vancomycin incubated without SC fibroblasts (orange line) after 48 hours (figure 4.7B). 
This pattern was consistent across a range of initial vancomycin concentrations (0 to 500 
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μg/mL), which indicated that vancomycin degradation was not enhanced by the presence 
of SC fibroblasts during the first 48 hours.  
Having established that SC fibroblasts do not degrade vancomycin under these in vitro 
conditions, the next step was to model clinical vancomycin delivery using the S-JIM. For 
the purpose of preventing orthopedic infections, vancomycin can either be applied 
directly to the surgical site as a powder or injected into circulation. The direct intrawound 
application of vancomycin was modelled in the S-JIM by smearing vancomycin powder 
directly onto the innermost layer (embedded with C. acnes) at a surface coverage of 7.4 x 
102 mg/mm2. The intravenous delivery of vancomycin was modelled by dissolving 
vancomycin powder in the S-JIM culture media. Media vancomycin concentrations of 5 
μg/mL to 20 μg/mL were selected for this experiment, representing the clinical consensus 
for the lower and upper limits of effective trough serum concentrations for infection 
prophylaxis in the average adult.81,82  
To assess C. acnes survival following the two approaches of vancomycin application in 
the S-JIM, the innermost strip was removed after 48 hours of co-culture, washed briefly 
in fresh cell culture media, and a 100 μL aliquot of this media was plated onto BHI agar. 
Resulting colony counts correlated with the relative survival of C. acnes after co-culture 
in the S-JIM model. There were no significant differences in colony counts between the 
two C. acnes strains across experimental conditions. C. acnes colonies consistently 
appeared in all replicates when vancomycin was absent in either the S-JIM or the culture 
media, indicative of C. acnes survival following co-culture in the S-JIM. In contrast, no 
C. acnes colonies were observed when vancomycin was applied directly as a powder or 
dissolved in DMEM-soy at a concentration of 20 μg/mL. However, at a lower 
vancomycin concentration of 5 μg/mL, C. acnes colonies were observed in half of the 
experimental replicates. The average colony count at this reduced vancomycin 
concentration was fewer than the one presented in the no vancomycin condition (22 vs 
705 CFU/mL), which suggests that vancomycin was effective at reducing C. acnes 
survival in the S-JIM but did not completely eradicate the bacteria in half of the replicates 
(Table 4.2). These results indicate that vancomycin was effective against C. acnes when 
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applied directly as a powder and dissolved in media at a sufficiently high concentration, 
























Figure 4.7. SC fibroblasts do not alter vancomycin degradation rate.  
SC fibroblasts were cultured in 3D collagen as described in the FBCC model (methods 2.2). Vancomycin 
hydrochloride powder was dissolved in cell culture media and incubated with SC fibroblasts for 48 hours. 
A 50 μL aliquot of this media was pipetted onto a paper filter and positioned in the center of a BHI agar 
plate evenly spread with C. acnes. Agar plates were incubated anaerobically (0% O2, 5% CO2, 37° C) for 
96 hours to allow for C. acnes growth. Radii of zones inhibitory to C. acnes growth were measured and 
correlated to the initial vancomycin concentrations. (B) Zones of inhibition are shown for vancomycin-
containing cell culture media following incubation with SC fibroblasts. Blue and orange lines represent 
dataset with and without SC fibroblasts, respectively. There were no significant differences in vancomycin 
degradation between samples cultured in the presence and absence of SC fibroblasts. All experiments were 
performed in triplicate (N = 3). 
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4.7.3 Detecting C. acnes PJI by Desorption Electrospray Ionization 
Mass Spectrometry 
As previously mentioned, the ideal diagnostic approach for C. acnes PJI would be a 
point-of-care assay that can provide a rapid diagnosis while the patient is on the operating 
table. The iKnife is a newly developed surgical tool that may allow surgeons to 
accomplish this by scanning for microbe-specific molecular markers in periprosthetic 
tissues during an operation. In brief, the iKnife functions by sublimating a region of 
tissue, creating a gaseous sample that is subsequently analyzed by rapid evaporative 
ionization mass spectrometry.94 This suggests that the iKnife may be capable of 
differentiating between healthy tissues and C. acnes-infected tissues. However, it is 
currently unclear whether C. acnes biomarkers are detectable in connective tissues using 
mass spectrometry. 
The S-JIM model was used to provide proof-of-concept for the use of mass spectrometry 
in detecting a C. acnes PJI. In brief, S-JIM strips mimicking connective tissues were 
embedded with collagen or collagen with SC fibroblasts and coated with C. acnes CA01. 
The strip surface was then scanned using DESI-MS, and relative m/z signal intensities 
were translated into a representative 2D field-of-view image. Each pixel represents a 
DESI-MS datapoint correlating to an individual physical location on the S-JIM strip. 
Relative signal intensities were generated for a full m/z spectrum of 100 to 1000 for each 
pixel. The field-of-view images resulting from the relative signal intensities at m/z = 377 
and m/z = 473 are shown in figure 4.8. 
The identities of the m/z = 377 and m/z = 473 ions are unknown, but the data suggests 
they are specific to C. acnes and SC fibroblasts respectively. The images at m/z = 377 
(Figure 4.8A) display high-intensity signals (yellow) corresponding to the regions where 
C. acnes was smeared on the surface. Conversely, at m/z =473 (Figure 4.8B), the high-
intensity signals were no longer present. Rather, these imaged regions were entirely 
uniform in low-intensity signals (blue). There were however high intensity signals 
corresponding to the S-JIM strip embedded with SC fibroblasts. These data indicate the 
possibility of independently identifying the presence and location of SC fibroblasts and 
C. acnes within a PJI using DESI-MS. 
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Figure 4.8. Detection of Ions Specific to C. acnes and SC fibroblast in S-JIM strips. 
Surfaces of glass microscope slides, S-JIM strips embedded with collagen and without cells, and S-JIM 
strips embedded with collagen and SC fibroblasts were coated with C. acnes and scanned using Desorption 
Electrospray Ionization Mass Spectrometry (methods 2.4). Raw desorption data was translated into 2D 
field-of-view images for ions with (A) m/z = 377, (B) m/z = 473, and (C) m/z = 283. Signal intensity is 
displayed as follows: blue (low), red (medium) and yellow (high). All DESI-MS handling and analyses 






5 Shoulder-Joint Implant Mimetic (S-JIM) 
5.1 C. acnes Induces a Pro-Inflammatory Response in SC 
Fibroblasts 
Quantitative PCR analyses of SC fibroblasts gene expression in the FBCC model (figure 
3.3) indicated an overall pro-inflammatory response following co-culture with C. acnes. 
This was expected, as inflammation is an established hallmark of microbial joint 
infection.95 Additionally, consistent with our findings, C. acnes has been previously 
shown to secrete porphyrins, most commonly coproporphyrin III, that cause 
inflammation by generating reactive oxygen species.96 C. acnes can also express and 
secrete CAMP factor during an acne outbreak, which initiates an inflammatory response 
by causing the cell death of sebocytes in sebaceous glands.97 However, it is interesting to 
note that despite strong evidence suggesting that C. acnes induces host tissue 
inflammation, common serum inflammatory biomarkers such as C-reactive proteins, 
erythrocyte sedimentation rate, and white blood cell counts are oftentimes reportedly 
unchanged throughout a C. acnes infection.58,59 This apparent discrepancy between local 
and systemic responses to inflammation may be indicative of inefficient endocrine 
signaling at the site of infection, likely due to the poor vascularity of the dense connective 
tissues lining the post-operative shoulder joint. 
Of the five inflammatory cytokines that were observed, IL-6, TNF, and CCL2 gene 
expression levels were significantly different between SC fibroblasts that were co-
cultured with C. acnes for 24 and 48 hours (figure 3.3). IL-6 (Interleukin 6) is a central 
pleotrophic cytokine that functions as the chief stimulator for the production of most 
plasma proteins involved in acute inflammation.85,86 Given its important role in 
promoting inflammation, it is unsurprisingly that its gene expression was significantly 
upregulated 3 to 4-fold in SC fibroblasts after 24 hours of co-culture with C. acnes. The 
return of IL-6 gene expression to pre-infection levels after 48 hours of co-culture appears 
counterintuitive but may be attributed to a global repression of cellular processes – and 
thereby gene expression activity – in response to microbial infection. This hypothesis is 
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supported by the fact that 77% of the 4889 SC fibroblast genes with significantly altered 
expression activity were downregulated following exposure to C. acnes (figure 3.6). 
Furthermore, 20 of the 22 significantly enriched cellular pathways derived from RNA 
sequencing analysis (table S1) were also downregulated.  
A second explanation may be the presence of a negative feedback loop that serves to 
inhibit prolonged IL-6 production and prevent inflammatory tissue damage. One such 
self-regulatory pathway was recently discovered by Verboogen et al., in which newly 
synthesized IL-6 molecules bound to endosomal receptors while in transit to the plasma 
membrane.85 This activity resulted in the phosphorylation of STAT3 (Signal Transducer 
And Activator Of Transcription 3), which subsequently repressed the gene expression of 
IL-6. While it is not possible to determine the validity of these explanations based on the 
present data, our experiment does highlight the time-sensitive nature of IL-6 gene 
expression. Therefore, in consideration of recent studies that have proposed IL-6 as a 
biomarker of shoulder infection,98,99 it is advisable to remain cautionary in using this 
cytokine to diagnose PJIs.  
Similar to IL-6, TNF is a pro-inflammatory cytokine that coordinates a subset of plasma 
proteins involved in acute inflammation.86,87 Interestingly, TNF gene expression was 
unchanged in SC fibroblasts after 24 hours of co-culture with C. acnes, but significantly 
upregulated after 48 hours. This was completely contrary to the gene expression activity 
of IL-6 after 24 and 48 hours of co-culture. However, the result was expected, as TNF is 
one of the many pro-inflammatory regulated by IL-6 following prolonged exposure to 
microbial endotoxins.88 The increased gene expression of IL-6 after 24 hours was likely 
responsible for repressing TNF gene expression. It is also important to note that IL-6 
reportedly does not regulate anti-inflammatory cytokines88, which explains why IL-10 
gene expression levels were consistent after 24 and 48 hours of co-culture.  
The TNF and IL-17 pro-inflammatory signaling pathways (figure S1) were the only two 
cellular pathways that were enriched by the RNA sequencing analyses but did not reflect 
an overall decrease in gene expression. Although more of the genes in these two 
pathways were downregulated than upregulated, it is interesting to note that most of the 
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upregulated genes in these pathways were downstream transcriptional targets, whereas 
most of the downregulated genes encoded early signaling molecules such as transcription 
factors. These results are consistent with our previous observations of the temporal 
regulation in cytokine gene expression (figure 3.3) and further support the existence of a 
negative feedback mechanism that inhibits the inflammation signaling cascade after the 
final gene products have been generated.  
5.2 Limitations of the FBCC Model 
The FBCC model provided a reliable system to rapidly assess the impact of C. acnes on 
the gene expression of SC fibroblasts under hypoxic (2% O2) conditions that are 
characteristic of the shoulder joint. In theory, it was also possible to assess the impact of 
SC fibroblasts on the gene expression of C. acnes using the same RNA sequencing 
dataset. This was our initial goal, however the percentage of microbial transcripts in the 
extracted RNA pool was too low and provided an insufficient read count for genome 
alignment. It was later determined that this was likely because our RNA extraction 
protocol (Direct-zol RNA MiniPrep kit from Zymoresearch) did not include a sufficient 
Trizol incubation period to fully dissolve the peptidoglycan in C. acnes cell walls, 
resulting in underrepresentation of microbial RNA in the extraction. Fortunately, most of 
the microbial RNA in the samples could be filtered from the raw data and ultimately did 
not interfere with downstream analyses of the SC fibroblasts transcriptomic profile. 
The FBCC model, while efficient, is limited in its content validity and range of possible 
data collection methods. First, the FBCC model only provided a constant 2% O2 
environment rather than the dynamic range of oxygen levels present in the different 
layers of shoulder connective tissue. Second, the FBCC model did not consist of an 
implant surface, which was reportedly necessary for microbial growth in mice models of 
PJI.52 Third, it was not possible to assess gene expression changes or directly image cells 
at different layers of the fragile collagen disc due to a lack of a scaffolding framework. 
Fourth, the FBCC model can only capture gene expression changes from the entire 
population of SC fibroblast and C. acnes cells, but not cells at specific locations and 
distances apart. These limitations suggest that the gene expression analyses derived from 
the FBCC model may not accurately represent the actual gene expression changes in SC 
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fibroblasts in vivo. The S-JIM model was designed to address these four limitations and 
provide superior content validity for future experiments. 
5.3 Potential Improvements to the S-JIM Model 
The results in this thesis highlight the development of the first 3D laboratory biomimetic 
of an artificial human shoulder joint. While the S-JIM provides several advantages over 
2D cell cultures for studying PJI, such as the presence of an implant surface and the 
generation of a physiologically representative oxygen gradient across tissue layers 
(figure 4.2), there are some limitations to the model design. For example, the S-JIM is a 
stationary model and does not articulate like a functional shoulder joint. Consequently, 
there would be a lack of periodic fluid circulation, which would naturally be present in a 
post-operative synovial joint cavity.100 The absence of fluid flow would likely hinder C. 
acnes migration in the S-JIM, as it lacks the cellular structures required for autonomous 
motility.41 This limitation could be mitigated by culturing the S-JIM on a shaker that is 
periodically controlled, although this could compromise the setup needed to achieve 
anaerobic conditions.  
The S-JIM was developed as a co-culture system, but the only human cell type included 
in the current model is the SC fibroblast. While it is impractical to aim for a complete 
cellular representation of capsular connective tissue within a single model, the addition of 
circulating immune cells would be beneficial given the context of infection. As indicated 
by the gene expression analyses of SC fibroblasts from the FBCC model, the pro-
inflammatory TNF and IL-17 signaling pathways were activated by the presence of C. 
acnes but remained unresolved after 48 hours (figures 3.3 and S1) due to the lack of an 
immune response. One method of replicating the immune response in the S-JIM could 
involve supplementing the cell culture media with the buffy coat of a patient blood 
sample (i.e. a concentration of all the white blood cells and platelets). Alternatively, 
introducing THP-1 monocytes (an immortalized cell line routinely used for in vitro 
studies) at the outermost layer of the S-JIM could mimic the physiological process 
whereby monocytes transform into macrophages and migrate through the tissue layers in 
response to pro-inflammatory cytokines. This latter approach would provide less 
experimental validity, but presumably allows easier assessment of cellular responses 
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given the lower number of total cell types in the S-JIM. These putative improvements to 
the S-JIM model would allow us to investigate if the adaptive immune response can 
effectively clear early C. acnes infections, or whether the infection can achieve a critical 
mass in time to evade the host immune response. 
Another important consideration is that the S-JIM may not represent the actual number of 
C. acnes cells present throughout the stages of an in vivo PJI. Infection in patients likely 
initiates at the site(s) of contamination and gradually propagates across the implant. In the 
S-JIM, C. acnes was instead evenly distributed in the strip at a concentration of 5.0 x 106 
cells/mL of collagen, resulting in a bacterial count that is presumably greater than the 
amount present in an in vivo PJI. A more physiologically representative C. acnes count 
was not replicated in the S-JIM model in order to ensure that an in vitro PJI could be 
generated within a reasonable timespan (2 to 4 days) as opposed to the several weeks to 
months of lag time that often precedes the clinical onset of PJI.7 As such, the detection of 
C. acnes biomarkers from the DESI-MS scan may portray an overly-optimistic view of 
the ability to detect C. acnes in patient tissues. Conversely, the clinical effectiveness of 
intravenous vancomycin prophylaxis may be greater than the data presented in this thesis 
given the lower quantity of C. acnes that would need to be eradicated in patient tissues. 
Future S-JIM experiments seeking a more realistic temporal representation of the 
infection process should either lower the initial C. acnes concentration or apply C. acnes 
at a single point on the implant surface, allowing the infection to develop across the 
implant surface. 
5.4 SC Cell Death in the Presence of C. acnes 
The SC fibroblasts were viable at all oxygen levels tested in the S-JIM when cultured in 
the absence of C. acnes (figure 4.3). This is an important distinction between the S-JIM 
and the TRACER model that the S-JIM was cross-purposed from. In TRACER, cells 
were viable in the oxygen-abundant outer strip layers, but the majority were non-viable 
near the hypoxic core.90 We hypothesize this is because the SKOV3 and MCF7 tumor 
cell lines used in TRACER exhibit greater metabolic activity, and thereby an increased 
rate of oxygen consumption, compared to non-cancerous cells in homeostasis. In contrast, 
the SC fibroblasts used in the S-JIM exhibit a low metabolic rate in vivo and have 
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correspondingly low oxygen requirements, presumably as an adaption to the low oxygen 
environment of a normal joint capsule.  
The cellular lysis of SC fibroblasts observed in response to co-culture with C. acnes in 
the S-JIM is consistent with clinical reports of tissue necrosis in PJI.21 While the 
molecular mechanisms by which C. acnes induces cell lysis in a PJI is unclear, the live-
dead cell assay (figure 4.3) suggests that the microbial influence was localized to the 
innermost layers that were in physical contact with C. acnes. This suggests that C. acnes 
cells in the S-JIM did not migrate from their initial site of culture, consistent with the 
nature of C. acnes as a non-motile microorganism.41 Accordingly, the direct intrawound 
application of antimicrobial powders as a surgical prophylaxis would predictably be 
effective against C. acnes PJI, as it targets the initial site that C. acnes would adhere to.  
5.5 Bactericidal Efficiency of Vancomycin Against C. acnes 
in the S-JIM. 
The application of vancomycin powder in the S-JIM effectively eliminated both the 
repository skin-derived (ATCC 11827) and deep tissue-derived (CA01) C. acnes strains 
across all experimental replicates (table 4.2), which reinforces direct intrawound delivery 
of vancomycin as an effective clinical prophylaxis against C. acnes in shoulder PJI.  
Vancomycin also eliminated C. acnes in the S-JIM when dissolved at 20 μg/ml in the 
media. However, when this concentration was reduced to 5 μg/ml, there were 
observations of C. acnes survival in some experimental replicates despite the fact that this 
concentration was ten times higher than vancomycin’s previously reported minimal 
inhibitory concentration (MIC50 = 0.38 μg/ml and MIC90 = 0.5 μg/ml).
92 One explanation 
for this discrepancy might be inefficient vancomycin diffusion across the S-JIM layers, 
designed to mimic the connective tissue surrounding an avascular prosthetic joint. The 
thickness and permeability of the S-JIM layers may not be directly comparable to that of 
shoulder connective tissue, but it is noteworthy that collagen, the protein that constitutes 
the extracellular matrix in the S-JIM, represents most of the dry weight composition in 
connective tissues (60% in articular cartilage, 80% in joint ligaments, and 70% in 
tendons).101–103 This suggests there is at least a similar degree of permeability between 
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extracellular matrices of the S-JIM and capsular tissues from a structural perspective. The 
S-JIM data therefore highlights the potential for physiological barriers in the shoulder to 
limit vancomycin administration to an avascular prosthesis in sufficient concentrations to 
prevent infection. Long-term intravenous administration of vancomycin may reduce C. 
acnes numbers in a PJI to aid the host immune response but is unlikely to be as effective 
as direct intrawound application. 
The drawback to these experiments is that the toxicity of vancomycin on host fibroblasts 
was not thoroughly explored. While vancomycin would not be expected to act on 
fibroblasts given that its mode of action involves blocking the synthesis of 
peptidoglycan cell walls, long-term exposure (48 h) to a vancomycin concentration above 
3 mg/cm2 has been reported to be significantly cytotoxic to fibroblasts.104 Furthermore, 
there have been reports of increased operative complications and prolonged wound 
healing associated with intrawound vancomycin delivery in knee arthroplasty patients.105 
Fortunately, intrawound delivery of vancomycin has also been reported to yield effective 
therapeutic levels within post-operative knee and hip joints while systemic vancomycin 
concentrations remain at subtherapeutic or even undetectable levels.106 The fibroblasts 
used in our experiments did not show any phenotypes indicative of cell lysis when 
observed under a light microscope (data not shown) but they were not observed beyond 
24 hours. The potential for long term detrimental effects of vancomycin powder 
application on shoulder connective tissue cell viability cannot be ruled out without 
additional and much more comprehensive analyses. 
5.6 Explanations for the Lack of Biofilm Formation in the S-
JIM 
The SEM images (figure 4.4) revealed that while individual C. acnes cells adhered to the 
S-JIM implant surface, extracellular polymeric substances that are characteristic of C. 
acnes biofilms45 were not detected. This contrasts with previous studies of C. acnes 
PJIs.21,46,58,107 However, while biofilm formation is generally regarded as a hallmark of C. 
acnes PJI, it is noteworthy that no studies so far, to the best of our knowledge, have 
directly imaged C. acnes biofilms from an infected implant that has been extracted from a 
patient. It is, therefore, possible that C. acnes may not form the typical biofilm matrices 
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that are routinely observed in vitro within the environment of an infected human joint. 
This hypothesis is consistent with the observation that biofilms do not appear to be 
essential for at least some of the infectious properties of C. acnes. For example, as the 
cell viability assays (figure 4.3) and SEM images (figure 4.4) demonstrate, the ability of 
C. acnes to engender cell lysis in adjacent fibroblasts and adhere to the implant surface 
occurred in the absence of biofilms. Confirming the in vivo C. acnes biofilm structure 
would be a critical next step in determining whether the absence of biofilms in the S-JIM 
is physiologically representative or a limitation in the model. 
From the follow-up experiments exploring in vitro C. acnes biofilm formation on 
horizontal surfaces, it was evident that changes to media concentration (figure 4.5B), 
serum concentration (figure 4.5C), or surface roughness (figure 4.5D) were ineffective 
in converting C. acnes from a planktonic to biofilm mode of growth. Interestingly, the 
only method that succeeded in promoting C. acnes biofilm formation was changing the 
DMEM-soy co-culture media we developed back to BHI, one of the routine microbial 
growth medias for culturing C. acnes (figure 4.5A). Comparatively, DMEM does not 
contain a lipid metabolic source whereas BHI presumably does as it is comprised largely 
of cow brain extract.108 These lipids are generally serve as component building blocks for 
microbial biofilms109 and may be necessary act as a signal C. acnes biofilm formation, 
given that the bacteria naturally forms biofilms in the lipid-rich sebaceous glands.34 
Regardless of the specific factor(s) that enabled C. acnes biofilm formation in BHI but 
not DMEM, the result could not be replicated in the S-JIM with BHI, which indicates 
there is another factor hindering C. acnes biofilm formation. 
The biophysical mechanisms underlying microbial biofilm development aids in 
explaining the discrepancies in C. acnes biofilm formation between 2D culturing 
conditions and the S-JIM. During the initial stages of biofilm formation, rod-shaped 
bacteria under 10 μm in length have been experimentally shown to aggregate into a 3D 
cluster of radially-aligned cells that are vertically-aligned to the surface (figure 5.1).110 
The transition of cells from a horizontal to vertical orientation is driven by localized 
mechanical instabilities caused by the lengthening and division of neighboring cells. 
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Given that radial length of C. acnes is between 3 to 5 µm,111 the initiation of its biofilm 
likely adopts the same pattern.  
The role of this 3D conformation is not currently understood, but one possible function 
could be to increase the local cell density. This is achieved by the vertical side-by-side 
packing of cells, which would allow more cells to occupy a given surface area compared 
to if they were radially-aligned with the surface. Importantly, once C. acnes reaches a 
critical cell density, the bacteria undergoes quorum sensing and begins to secrete 
autoinducer AI-2.46 This molecule subsequently triggers a signaling cascade that results 
in the upregulation of several genes involved in biofilm formation. It is therefore 
tempting to speculate that the formation of this 3D conformation is at least partially 
responsible for triggering the expression of quorum signals that enable C. acnes to 
transition from a planktonic to biofilm mode of growth.  
If this hypothesis is correct, then C. acnes in the S-JIM may not have entered the biofilm 
mode of growth because such a conformation would be unlikely to form on a vertically 
orientated implant surface. This is because C. acnes has been observed to sediment in a 
stationary culture (data not shown), and cells that align perpendicular with the vertical 
surface may lack the surface contact required for adherence to the implant. This 
explanation would be consistent with our experiments wherein C. acnes biofilms formed 
on horizontal surfaces but not on the vertically oriented S-JIM surface. It may therefore 







Figure 5.1. 3D Microbial Clustering During Biofilm Initiation. (A) Top-down and (B) 
side view of microbial biofilm initiation after transformation into a computer model. 
Vertically and horizontally aligned cells are labelled red and blue, respectively. Images 















5.7 Prospective Real-Time Detection of C. acnes PJIs 
Using Mass Spectrometry 
The DESI-MS experiments highlighted the use of a C. acnes-specific molecular ion to 
detect regions of “infected” bioartificial tissue. The identity of this molecular ion was not 
confirmed in this thesis, as the experiments only served to provide proof-of-concept, and 
more specific ions have been previously reported. For example, Teramoto et al., 
demonstrated that matrix-assisted laser desorption/ionization mass spectrometry analyses 
of ribosomal subunit proteins to not only detect C. acnes, but also to classify individual 
strains into the six main phylotypes.112 The ability to identify C. acnes strains beyond the 
species level suggests that mass spectrometry approaches engender sufficient specificity 
for the clinical detection of C. acnes in PJIs.  
Adoption of mass spectrometry-based detection approaches could potentially be realized 
by using the novel iKnife™ – a handheld diathermy device that sublimates a selected 
region of tissue and immediately processes it using rapid evaporative ionization mass 
spectrometry (REIMS).94 The molecular ions that are detected from the tissue sample are 
subsequently screened against a set of standard molecular markers based on their m/z 
ratios to characterize the sample. This process would allow surgeons to rapidly 
differentiate between “infected” and “non-infected” connective tissue during an 
operation. While the iKnife™ has so far only been used intraoperatively to assess in vivo 
tissues such as brain tumors113,114 and colorectal mucosa,115 its adoption for detecting 
microbial infections in patient tissue remains an unexplored but feasible possibility.  
Further experiments would need to be conducted using the S-JIM before clinical testing 
is possible. In this thesis, DESI-MS was used in place of REIMS due to ease of 
accessibility. However, given that REIMS involves a more destructive sample analysis 
approach compared to DESI-MS,116 it is unclear if the same experimental outcomes 
would result. Furthermore, to rule out the possibility of cross-microbial detection, the 
selected molecular ions must be tested against other common agents involved in shoulder 
PJI, such as Staphylococcus aureus. Despite these limitations, the present data has 
provided an optimistic proof-of-concept view for the real-time detection of C. acnes PJIs 
using mass spectrometry. 
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5.8 Conclusion 
To our knowledge, the S-JIM is the first in vitro 3D model of PJI that includes surgical 
metals and supports a co-culture of anaerobic bacteria and human capsular fibroblasts. 
The S-JIM provides substantial advantages over existing animal models and 2D cell 
culture systems for studying PJI, such as a physiologically accurate oxygen gradient and 
the ability to assess cellular and molecular interactions at several tissue layers. These data 
demonstrate the practicality of using the S-JIM to successfully address clinical inquiries 
such as the effectiveness of vancomycin prophylaxis and the prospective use of mass 
spectrometry as a point-of-care approach to detect C. acnes infections. While it is 
currently unclear whether C. acnes biofilms form in vivo, the S-JIM nevertheless has 
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Table S1. SC Fibroblast Cellular Pathways with Enhanced Gene Expression 
Following Co-culture with C. acnes in the FBCC Model. RNA libraries 
were prepared from SC fibroblasts and C. acnes following 48 hours of co-culture and 
genes with a 2-fold or greater increase or reduction in expression were categorized into a 
list of pre-available cellular pathways using Partek Flow® data analysis software (method 
2.6.6). Cellular pathways with significant changes in gene expression (p < 0.01) were 











Figure S1. Differential gene expression of the (A) TNF and (B) IL-17 signaling 
pathways in SC fibroblasts in response to C. acnes.  
Genes highlighted in green or red displayed significantly increased or decreased 
expression respectively (p < 0.01) by at least two-fold in response to co-culture with C. 
acnes. Early response genes (cytokines and transcription factors) and downstream 
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